Letter to the Editor

Page 2

Posts about this type

JCP
Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use
Letter to the Editor

January 22, 2024

The authors provide additional relative risk data in response to Dr Andrade’s comments on their study.
Heidi Taipale, Marco Solmi, Christoph U. Correll, et al
JCP
Testing for Sleep-Disordered Breathing in Psychiatric Practice
Letter to the Editor

January 10, 2024

Dr Barry Krakow comments on Benca and colleagues’ recent review of sleep apnea in psychiatric practice and calls for clinicians to screen for sleep-disordered breathing at intake.
Barry Krakow
PCC
Deprescribing Benzodiazepines: Is Harm Reduction Enough?
Letter to the Editor

December 28, 2023

Vania Modesto-Lowe, MD, MPH, and Claire N. Aurilio, BS, comment on a recent publication in the PCC.
Vania Modesto-Lowe, Claire N. Aurilio
PCC
Commentary on Catatonia and Competency to Stand Trial
Letter to the Editor

December 26, 2023

N. A. Uvais, MBBS, DPM, comments on a recent publication in the PCC.
N. A. Uvais
PCC
Psychotropic-Related Sexual Dysfunction: Clinical Insights
Letter to the Editor

December 21, 2023

Clinicians should be cognizant of and avidly screen for psychotropic-related sexual dysfunction during routine follow-up clinic visits.
Ahmed Naguy
PCC
Insights Into Poststroke Depression
Letter to the Editor

August 31, 2023

The authors shed light on risk factors, purported mechanisms, diagnostic tips, and treatment options for poststroke depression.
Ahmed Naguy, Bibi Alamiri
PCC
Comment on the Midlevel Care Provider System in New York State
Letter to the Editor

August 24, 2023

This letter explores a provider type that is part of the solution to the psychiatric shortage: psychiatric pharmacists.
Carla D. Cobb, Michael D. Shuman, Tammie Lee M. Demler
JCP
Safe Delivery of TMS to Patients With Implanted Devices
Letter to the Editor

July 12, 2023

Tendler et al argue that, in considering transcranial magnetic stimulation (TMS) treatment, providers should refer to recent guidelines and literature reports instead of universally excluding patients based on outdated,...
Aron Tendler, Yiftach Roth, Colleen A. Hanlon
PCC
Creating Informed Interest in Mal De Débarquement Syndrome
Letter to the Editor

July 11, 2023

In this letter to the editor, Jun Maruta, PhD, and colleagues comment on a case report previously published in the PCC.
Jun Maruta, Sergei B. Yakushin, Catherine Cho
PCC
Mal de Débarquement Syndrome Complicated by Psychiatric Comorbidities: Response to Maruta et al
Letter to the Editor

July 11, 2023

Anil K. Bachu, MD, responds to Maruta and colleagues regarding a case report previously published in the PCC.
Anil K. Bachu
JCP
Daridorexant: Caution Is Needed About Suicidal Risk in Depressed Patients With Insomnia—Reply to Palagini et al
Letter to the Editor

July 3, 2023

Bénédicte Nobile, PharmD, PhD, and Philippe Courtet, MD, PhD, continue the discussion of potentially increased suicidal risk with daridorexant, a new hypnotic.
Bénédicte Nobile, Philippe Courtet
JCP
Aggravation of Suicide Risk With Daridorexant: Currently Not Enough Data to Show a Link
Letter to the Editor

July 3, 2023

Palagini and colleagues comment on a recent letter that suggested a role for daridorexant, a new hypnotic, in increasing suicide risk.
Laura Palagini, Pierre A. Geoffroy, Jean Arthur Micoulaud-Franchi, et al
PCC
Comment on Palinacousis or Auditory Perseverations and COVID-19 Vaccination
Letter to the Editor

June 27, 2023

In this letter to the editor, Amnuay Kleebayoon, PhD, and Viroj Wiwanitkit, MD, comment on a report published recently in the PCC.
Amnuay Kleebayoon, Viroj Wiwanitkit
PCC
Varenicline Use for Cocaine Dependence
Letter to the Editor

May 30, 2023

In this letter to the editor, Abhishek Gupta, MBBS, reviews the latest research on the use of varenicline in cocaine dependence.
Abhishek Gupta
PCC
Zoom Dysmorphia and Body Dysmorphic Disorder
Letter to the Editor

April 27, 2023

In this letter to the editor, Tomás Teodoro, MD, MSc, comments on a report recently published in the PCC.
Tomás Teodoro
PCC
Neuropsychiatric Manifestations of Mpox
Letter to the Editor

April 18, 2023

Rujittika Mungmunpuntipantip, PhD, and Viroj Wiwanitkit, MD, comment on a report recently published in the PCC.
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
PCC
Lurasidone-Induced Urinary Retention
Letter to the Editor

April 4, 2023

Gregory M. Asnis, MD, comments on a report recently published in the PCC.
Gregory M. Asnis
PCC
Comment on Huntington’s Disease With Psychotic Features
Letter to the Editor

March 7, 2023

Herwig Lange, MD, comments on a report previously published in the PCC.
Herwig Lange
PCC
State of the Art of Diagnostics and Genetics in Huntington’s Chorea
Letter to the Editor

March 7, 2023

Mayank Gupta, MD, and Christoph U. Correll, MD, respond to Herwig Lange, MD, regarding their previous case report of a patient with Huntington’s disease.
Mayank Gupta, Christoph U. Correll
PCC
Buprenorphine Maintenance in the Fentanyl Era
Letter to the Editor

February 14, 2023

Methods to foster patient adherence and physician acceptability of buprenorphine maintenance are needed to incorporate this treatment into primary care for fentanyl users.
Vania Modesto-Lowe, Lakshit Jain
JCP
Possible Suicidal Risk With Daridorexant
Letter to the Editor

December 7, 2022

Instructions for use of the new anti-insomnia medication daridorexant mention cautious use in patients with history of suicidal behavior. This letter explores the factors that underlie this recommendation for...
Bénédicte Nobile, Emilie Olié, Philippe Courtet
JCP
Pregnancy Outcomes After SGA Exposure: Extracting More From the Data
Letter to the Editor

November 30, 2022

Malathi Perugula, MD, and colleagues call attention to design aspects of a recent study on antipsychotic use in pregnancy.
Malathi Perugula, Ramu Vadukapuram, Chintan Trivedi, et al
JCP
Reply to Perugula et al: Toward Improving Reliability of Safety Information on Drug Exposure in Pregnancy
Letter to the Editor

November 30, 2022

Naho Yakuwa, BPharm, responds to Perugula and colleagues about a recent study on SGA use during early pregnancy.
Naho Yakuwa
JCP
Stigma Kills Psychiatric Patients and Is Now Killing Clinical Research Too
Letter to the Editor

November 28, 2022

Robert M. Post, MD, argues that NIMH should abandon the RDoC framework and restore funding for clinical research.
Robert M. Post

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe